October 21, 2019

Proactive steps paramount for greater surgical stapler safety

By: OR Manager
Share

Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I.

ECRI Institute named malfunction associated with surgical stapler misuse the number one hazard on its Top 10 Health Technology Hazards for 2020. Surgical staplers are commonly used in high-risk surgical procedures, and misuse or malfunction of the devices can lead to serious complications, as ECRI Institute has seen during its research and accident investigations. Although the overall adverse event rate is actually quite low relative to how frequently they are used, adverse events do occur, and even rare instances of preventable death warrant scrutiny.

In May 2019, the FDA released a report summarizing 109,997 problem reports submitted for surgical staplers and staples since 2011. Of these, 412 involved deaths and 11,181 described serious injuries.

Hospitals can close the gap on surgical stapler safety by understanding how staplers work, recognizing how complications occur, and involving various stakeholders in patient safety efforts.

 

Internal stapler design

Internal surgical stapler designs vary depending on whether the device is intended for open or endoscopic surgery, as well as whether it will be used just to staple tissue or to both staple and cut. Some cutting models, for example, first seal the tissue with lines of staples, then transect those lines with a cutting mechanism to separate those parts of the anatomy. These specialized devices may be used when removing part of an organ, cutting through organs and tissues, and creating connections between structures.

Endoscopic linear cutter designs consist of a handle and shaft with jaws at the end that can be closed on the tissue of interest. The surgeon clamps onto the tissue and then fires the stapler. This action deploys rows of staples into the clamped tissue on either side of the intended cut line, followed immediately by a knife that travels down the channel in the stapler’s cut line, transecting the tissue between the symmetrical lines of deployed staples. In this way, the stapler seals the tissue on either side of the cut to prevent hemorrhage.

On circular models, the end of the staple cartridge is compressed against a circular anvil to bring two sections of tissue together, such as a bowel. Circular models are most commonly used for gastrointestinal (GI) anastomoses. Other designs are also available.

 

Stapler designs differ

Stapler models—even those of the same type—can vary pretty significantly from one brand to the next, despite performing similar functions. For example, here are several ways that models from the two major endoscopic linear surgical stapler manufacturers may differ:

• the design, selection, and color of the staple cartridges; the range of tissue thicknesses for which each cartridge is intended; and the method of cartridge installation and removal

• the method of stapler head articulation

• whether the stapler must be unlocked to indicate firing readiness, and whether tissue compression is recommended before firing

• the number of trigger pulls required for staple deployment and knife advancement

• the method for retracting the knife and for opening the stapler jaws after firing

• the number of recommended uses on a single patient before disposal.

These differences illustrate that experience with one stapler model does not necessarily translate into skill with another model.

 

Complications do occur

Bleeding or GI leaks can occur if a staple line is incomplete or does not hold. Such problems may be immediately apparent, or they may not appear until sometime later, leading to severe symptoms long after the patient has been closed up and sent for recovery. Patient harm in these events can range from no injury to fatality.

ECRI Institute has been called on to investigate many surgical stapler incidents over the past two decades. Our investigators have found that, in most cases, the stapler actually functions as intended. However, we’ve seen adverse consequences as a result of clamping on another instrument or clip, clamping on tissue that is too thick or too thin, or some other form of misuse. Poor staple line integrity can also occur with diseased, necrotic, or ischemic tissue.

 

ECRI Institute recommendations

Along with the FDA’s move to reclassify surgical staplers comes the implementation of effective special controls, such as improved device labeling. This should be a step forward, but it will take time. In the meantime, here are four steps that hospitals and providers can take now to improve surgical stapler safety.

• Improve event reporting. OR managers, risk managers, and patient safety officers can improve the quality of event reports in two ways. First, update reports as new information is obtained. For example, an event that is initially classified as a stapler “malfunction” (without injury) should be updated if an associated injury manifests days later. Second, establish an investigation plan. Risk management and frontline clinicians should know what to sequester, and should implement measures such as labeling disposables according to the chronology of their use and saving loose and malformed staples.

• Consider the user when making purchasing decisions. Anyone involved in purchasing surgical staplers, especially the OR manager, should consider user familiarity when making a large purchasing decision, such as switching an entire suite of endo-mechanicals from one manufacturer to another. Lack of user familiarity continues to be a contributing factor in adverse incidents. Involve the user in purchasing decisions to bring potential use issues to light before devices are placed into service.

• Recognize risks and plan ahead. Surgeons who use surgical staplers should be especially aware of the risk of immediate and serious hemorrhage in vascular applications. ECRI Institute recommends that the entire OR team have a back-up intervention planned in case of hemorrhage. Such planning can dramatically reduce patient harm.

• Improve user training. Ensure that surgeons are knowledgeable and experienced with the specific stapler model that will be used. Unexpected outcomes are less likely if the surgeon is knowledgeable about and experienced with the device before use. Develop appropriate training criteria for staplers with the manufacturer, including contraindications and what can go wrong, and verify that these are met before stapler use.

Reclassification by the FDA and the identification of special controls is a step in the right direction. But it is just a step, and the FDA is just one of the stakeholders with a role to play. Manufacturers can continue to improve device designs, and healthcare facilities can implement measures like those outlined above to prevent patient harm.

To learn more, contact ECRI Institute at (610) 825-6000, ext. 5891, clientservices@ecri.org, or visit www.ecri.org. To download the executive brief of ECRI Institute’s Top 10 Health Technology Hazards for 2020, visit www.ecri.org/2020hazards. ✥

Join our community

Learn More
Video Spotlight
Live chat by BoldChat